Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

7.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.7K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stabilizing Ru Atomic Clusters and Activating Interfacial Water Structure via Bridged p-Block In-N<sub>3</sub>O<sub>1</sub> Single Sites for High-Performance Alkaline Fuel Cells.

Angewandte Chemie (International ed. in English)·2026
Same author

Polymeric Hydrogel Interphase Enables Transport-Compatible Fe Stabilization for Hectowatt-Scale Alkaline Water Electrolysis.

Journal of the American Chemical Society·2026
Same author

Postoperative anlotinib plus radiotherapy in patients with newly diagnosed, unmethylated O<sup>6</sup>-methylguanine-DNA methyltransferase glioblastoma: A single-arm, phase 2 study.

Cancer·2026
Same author

Early clinical diagnosis of congenital insensitivity to pain with anhidrosis in an infant: a case report.

Frontiers in pediatrics·2026
Same author

Multi-Omics Analysis Reveals Age-Related Enhancements in Gut Morphology, Microbiome, and Metabolism of Tibetan Pigs.

Microorganisms·2026
Same author

Non-viral gene delivery systems for osteoarthritis therapy.

Biomaterials translational·2026

Related Experiment Video

Updated: Feb 19, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.6K

Galangin increases ERK1/2 phosphorylation to decrease ADAM9 expression and prevents invasion in A172 glioma cells.

Deqiang Lei1, Fangcheng Zhang1, Dongxiao Yao1

  • 1Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.

Molecular Medicine Reports
|November 9, 2017
PubMed
Summary
This summary is machine-generated.

Galangin, a natural flavonoid, effectively inhibits human glioma cancer cell migration and invasion. It achieves this by downregulating ADAM9 and extracellular signal-regulated kinase (Erk)1/2 pathways, suggesting potential as a glioma chemotherapeutic agent.

More Related Videos

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells
09:20

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells

Published on: July 6, 2021

2.8K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.9K

Related Experiment Videos

Last Updated: Feb 19, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.6K
Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells
09:20

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells

Published on: July 6, 2021

2.8K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.9K

Area of Science:

  • Natural product chemistry
  • Cancer biology
  • Molecular oncology

Background:

  • Galangin is a flavonoid with reported anti-cancer properties.
  • Glioma is a common type of brain cancer.
  • Understanding galangin's mechanism in glioma is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the effects of galangin on A172 human glioma cancer cells.
  • To elucidate the molecular mechanisms underlying galangin's anti-glioma activity.
  • To assess galangin's potential as a chemotherapeutic agent for glioma.

Main Methods:

  • A172 human glioma cells were treated with galangin.
  • Human proteinase array assay was used to identify target proteins.
  • Western blotting and RT-qPCR were employed to analyze protein and mRNA expression.
  • Extracellular signal-regulated kinase (Erk)1/2 pathway was investigated using inhibitors and siRNA.

Main Results:

  • Galangin inhibited A172 cell migration and invasion at non-toxic doses.
  • Galangin treatment reduced ADAM9 protein and mRNA expression.
  • Sustained extracellular signal-regulated kinase (Erk)1/2 activation was observed and linked to ADAM9 inhibition.
  • Inhibition of Erk1/2 reversed galangin's effect on cell migration and invasion.

Conclusions:

  • Galangin demonstrates anti-migratory and anti-invasive effects on human glioma cells.
  • The mechanism involves the downregulation of ADAM9 via the Erk1/2 signaling pathway.
  • Galangin shows promise as a potential chemotherapeutic agent for glioma treatment.